The current review aimed to elucidate the role of diet in every stage of inflammatory bowel diseases, from aspects of prevention, treatment and rehabilitation. Western diet, characterized by overconsumption of refined sugar and saturated fat and low consumption of dietary fiber, may partly be blamed for its pathogenesis. Some immune-modulated nutrients (fibers, monounsaturated fatty acids, n-3 polyunsaturated fatty acids and vitamin D) exert their potential beneficial effects on gut microbiota and immune function, resulting in clinical remission and/or preventing relapse. However, data is limited to conclude optimal micronutrient levels and therapeutic implications. Further, diet itself is complex; therefore, it is reasonable to evaluate diet as a whole rather than a single type of food. Some specific dietary patterns are generated for the management of inflammatory bowel diseases with controversial results. Only exclusive enteral nutrition has been widely recommended for pediatric patients with non-stricturing active Crohn's disease.
Self-monitoring, avoidance of certain types of foods, limited intake of alcohol and smoking, supplementation of minerals and vitamins if deficiency is confirmed, and adherence to the diet enriched in vegetables and fruits and low in animal food and un-digested fiber during flares are the most common dietary recommendation. Further clinical trials with a high evidence rank are warranted.
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| INTRODUCTION
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are characterized by progressive and relapsing dysfunction of the gastrointestinal (GI) tract. The incidence of IBD has been dramatically increasing in China during the recent decades, ranking first in Asia (3.44 per 100 000). 1 The shift from a traditional Chinese diet (high intake of whole grain and vegetables and low intake of animal meat) to a Western diet (high intake of animal fat and protein, refined sugar and processed food and low intake of vegetables and fibers) has partly contributed to the pathogenesis of IBD.
Excessive intake of n-6 and inadequate intake of n-3 polyunsaturated fatty acids (PUFAs) after industrialization is also blamed for the rising emergence of autoimmune diseases including IBD. 2 Obviously, diet is one of the most important driving factors of IBD, which is involved in every stage of the disease from the pathogenesis to rehabilitation as well as from flare to remission. However, no common dietary recommendations could be generated based on the evidence to date. 3, 4 Furthermore, most evidences are limited by study design, sample size, and lack of optimal control. Some of the potential mechanisms have to be investigated depending on animal or in vitro experiments.
In this review, we summarize the possible roles of diet in IBD, such as the interaction between specific nutrients and gut microbiota, the effects of pro-inflammatory and anti-inflammatory dietary ingredients on IBD, and clinical implementation of dietary intervention.
| DIET IN THE PATHOGENESIS OF IBD
The stability of gut microbiota is one of the most important mechanisms involved in maintaining normal immune functions. Food feeds not only the human body but also billions of bacteria known as "gut microbiota." Dietary factors, including some nutrients and dietary patterns, exert their effects on the pathogenesis of IBD through interaction with the gut microbiota.
| Imbalance of gut microbiota in IBD
Low diversity in gut microbiota is common among IBD patients, characterized by decrease in short-chain fatty acids (SCFAs)-producing bacteria, and butyrate-synthetic capacity. CD patients have a lower microbial diversity, a greater altered proportion in gut microbiota, and a more unstable microbial community compared with UC patients. 5 Reduced proportions of Firmicutes 6-8 and increased proportions of The magnitude of dysbiosis was associated with postoperative recurrence [13] [14] [15] among CD patients while restoration of gut microbiota diversity led to a better response to infliximab treatment. 16 But evidences from human studies are scarce. Both null and positive associations were reported by previous studies.
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Refined carbohydrates
Refined carbohydrates (e.g., sucrose and fructose syrup) are enriched in sugared-beverages and desserts. Two meta-analyses found no association between total amount of carbohydrate intake and the risk of IBD, but excessive intake of sucrose was associated with a high risk of both UC and CD. 24, 25 Every 10 g increment in daily intake of sucrose was associated with 10% more likelihood of IBD, of which the possible mechanism was the changes in gut microbiota. Another systematic review confirmed a positive relationship between sugared beverage consumption and the risk of UC, 26 especially for those with a low intake of vegetables for 2 years (between the highest and lowest quintile: incidence rate ratio 1.68, 95% confidence interval
[CI] 1.00-2.82). 27 We would like to advise IBD patients against the intake of refined sugar, such as sweetened beverage drinks, candy, deserts, etc.
Food additives
Two popular emulsifiers, carboxymethylcellulose (CMC) and polysorbate-80 (P80), lead to a remarkable reduction in microbial diversity and bacterial translocation, thereby resulted in a low-grade systematic inflammation and leading to robust colitis in mice. 28 Salt in processed food has also been proven to be a potential contributor to systematic inflammation and colitis in animal studies. 29 We cannot exclude the possibilities of harmful effects of food additives on IBD, although the relevant human data are deficient. Several prospective cohorts 22, 30 have been conducted to figure out the underlying relationship.
| Anti-inflammatory nutrients
Dietary fiber
Dietary fiber refers to a kind of complex carbohydrates which fails to be broken down by GI digestive enzymes. It is enriched in whole grain, . 31 But such a protective effect was only found in those having a higher intake of fibers derived from fruits rather than that from whole grain, legumes and cereals. 31 The anti-inflammatory effect of fruits is mainly due to the abundance of soluble fibers and their fermented metabolite (SCFAs) and is partly mediated by the aryl hydrocarbon receptor. However, a recent large cohort study (EPIC-IBD) 32 showed no statistically significant association between the intake of dietary fiber and the incidence of IBD except for the protective effect of cereal fiber on non-smoking CD patients.
It is of significance to supplement dietary fibers to restore the proportions of SCFAs-producing bacteria and the contribution of SCFAs production to improve inflammation. Low-residue diet is sometimes recommended during flare 33 and commonly implemented into clinical practice, but the evidence level is meager. Dietary fiber is not restricted among IBD patients in remission except those with strictures. 34, 35 One systematic review supported that the supplementation of dietary fibers enriched in vegetables and fruits as well as soluble fibers was beneficial for UC. 36 Besides, avoidance of dietary fiber would lead to higher relapse rate among patients with chronic nonstricturing CD. 37 Remarkably, fibers of different sources have varied effects on colitis, among which psyllium, pectin and cellulose fibers had protective effects contrary to methylcellulose. 38 Additionally, the effect of dietary fiber varies between CD and UC. A systematic review reported that a higher consumption of total fat, n-6 PUFA and meat increased the risk of both UC and CD. 23 Two other prospective cohort studies showed a positive relationship between the ratio of dietary n-6/n-3 PUFAs and the risk of CD, especially among those with specific polymorphisms in newly-diagnosed pediatric patients 57 or adult females. 58 In contrast, several large prospective cohort studies reported that the highest quartile of n-3/n-6 PUFA, 59 It is noteworthy that supplementation of dietary n-3 PUFAs could reduce the short-term relapse rate after 2-to 3-month follow-up in UC patients. Among patients with mild-to-moderate UC, supplementation of n-3 PUFAs could even replace sulfasalazine. 63, 64 Because DHA and EPA were enriched in sea fish, weekly supplementation of Atlantic salmon of 600 g for 8 weeks could also ameliorate the disease activity in active UC patients. 65 However, when considering long-term (2-year follow-up) effects, most previous studies found no obvious effects of daily oral fish oil intake on relapse rate, 66 except a weak effect on delaying early relapse. 66 Evidence is inadequate to draw a solid conclusion and daily supplementation of n-3 PUFAs is not recommended in ESPEN guidelines. 4 
| Dietary pattern
As food is a complex, it is more reasonable to evaluate the association between dietary patterns and the risk of IBD rather than a certain single nutrient or one type of food. For example, potential beneficial effect of high intake of fibers and fruits can possibly be explained by a low intake of fat and meat. 23 Generally, diets high in animal fat and low in fruits and vegetables are the most common pattern that is associated with an increased risk of IBD. 67 However, the existing epidemiological studies have reported mixed results. The prospective EPIC study reported that no dietary pattern was associated with a risk of either UC or CD; while after excluding cases occurring within the first 2 years after dietary assessment, a "high sugar and soft drink" pattern was positively associated with a higher risk of UC but not of CD. 27 Another small case-control pediatric study has even revealed that the association between diet and IBD is gender-specific. 68 Positive relationship between dietary pattern characterized by meat, fatty food and desserts and the risk of CD was found only in girl, but not in boys. 68 Diet rich in vegetables and fruits with a balanced ratio of n-3 to n-6 PUFA has been suggested to prevent IBD in ESPEN guidelines. 4 As confirmed in NHS II cohort, a prudent dietary pattern characterized by high intake of fruits, vegetables and fish had a protective effect on UC after 13-year follow-up. 69 A protective effect was observed in a diet enriched in vegetables, fruits, olive oil, fish, grains, and nuts in both genders among pediatric CD patients. 68 Interestingly, Mediterranean diet could be one of anti-inflammatory dietary patterns to meet the abovementioned demands and is recommended in our center, although limited studies supported this assumption in both UC and CD patients.
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3 | CLINICAL IMPLEMENTATION OF DIETARY INTERVENTIONS
| Food avoidance and exclusive dietary pattern
Approximately 57% of IBD patients believe that certain food is the trigger for disease relapse and over 60% of these patients deliberately underwent an elimination diet or avoid certain food. 72 Food avoidance is more common in active stricturing CD patients. 73 Spicy foods and alcoholic beverages are frequently avoided in both CD and UC patients. On the other hand, although most studies support that a high intake of dietary fiber has beneficial effects on IBD, the avoidance rates of fiber-enriched foods and raw vegetables in IBD patients under remission are 24.5% and 42% respectively. 74 The intake of fiber was reduced by half among pediatric IBD patients compared with recommended daily allowance and healthy children. 75, 76 Further, it should be taken into consideration that long-term avoidance of protein-enriched foods (diary, meat, fish) could aggravate malnutrition and deficiency of nutrients. Thus, the recommendation for intolerant foods should be treated individually and the principle is "If it hurts, don't do it."
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Exclusive dietary patterns were developed to remove proinflammatory components or food allergens and/or to add antiinflammatory ingredients to maintain remission or relieve irritated bowel symptoms (Table 1) . However, the data is insufficient to support such a recommendation. Poor adherence and cultural differences makes it unpopular in China.
| Enteral nutrition (EN)
Exclusive enteral nutrition (EEN) refers to an "extreme" form of artificial exclusive diet and modulates the gut microbiota to an antiinflammatory state. 88 To date, it is the only recommended first-line treatment option for inducing remission in pediatric patients with active CD in recent guidelines, 4 reconfirmed in latest systematic review this year (RR 1.45, 95% CI 1.03-1.97). 89 A treatment of EEN for 4 to 10 weeks could lead to remission rate as high as 86% in pediatric active IBD patients to avoid drug-induced growth retardation. SES-CD score was ≥1 (50% vs. 6%, P = 0.005). 91 Such protective effect could even last for as long as 10 years. 90 Even so, only 4% of children in the USA were suggested to try EN compared with 62% in Europe 92 as their first choice and definite data in China still lacks.
As for adult CD patients, corticosteroids remain the first-line treatment to induce clinical remission compared to EEN. 89 Poor compliance to EN formula and insufficient therapeutic course might be the main cause to underestimate its effect. EEN is more intended to relieve complex complication, either fistula or stricture, compared with monotherapy with infliximab, especially among those malnourished patients. 93 Besides, it could prolong 1-year remission rate along with infliximab therapy. 94 To reach the ideal therapeutic effect, the key is to improve patient compliance for a 12-week EEN treatment. Detailed communication should be fully conducted including the strength and limitation of EN, the choice of enteral formulation and route of administration, regular nutritional assessment and food re-introduction plan, etc. As different enteral formulations brought about no difference in remission rate, 89 the route and pattern of administration should be considered regarding well-tolerated compliance and quality of life.
As for those in remission, intermittent partial EN (provides ≥50%
of the required daily calorie intake) with nighttime infusion and Abbreviations: AID, anti-inflammatory diet (with restriction of intake of certain carbohydrates (lactose, refined carbohydrates and processed complex carbohydrates, modification of dietary fats and supplementation of pre-and probiotic foods); CD, Crohn's disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IgG4-guided exclusion diet, exclusion of 4 food types with the highest immunoglobulin G4 (IgG4) titer in true diet group, and the four most commonly excluded foods: beef, pork, eggs, milk; low FODMAP diet, limited intake of fructo-oligosaccharides (wheat, onions, legumes), lactose (milk, ice-cream), fructose (apples, honey), galactans (legumes) and sorbitol (stone fruits, artificial sweetener); Mediterranean diet, high consumption of olive oil, fruits, vegetables and cereals, moderate-to-high consumption of fish, and low consumption of non-fish meat; NR, not reported; SCD, special carbohydrate diet (exclusion of all grains, sugars except for honey, processed foods and milk); SD, standard deviation; SVD, semi-vegetarian diet (a lacto-ovo-vegetarian diet enriched in fiber); UC, ulcerative colitis.
daytime low-fat diet is an alternate dietary choice for quiescent CD patients 95, 96 to prevent relapse both in children and adult patients.
Besides, if EN or oral feeding is contraindicated or fails to meet 60% of the daily calorie for 1 week, parental nutrition should be taken into consideration. 
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